Lupin unit gets French regulatory nod for good manufacturing practices

| Updated on August 06, 2019 Published on August 07, 2019

Lupin says all its plants are governed by the same quality system   -  Bloomberg

Lupin on Tuesday announced the completion of the Good Manufacturing Practices (GMP) inspection of its finished products manufacturing facility (Unit-1) at Mandideep, by the French National Agency for Medicines and Health Products Safety (ANSM).

The inspection was conducted between April 8 and April 12. The ANSM inspection closed with no critical or major observations, Lupin said. Shares of Lupin closed 0.76 per cent lower at ₹750.90 on the BSE.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 07, 2019
This article is closed for comments.
Please Email the Editor